GCK and fatty liver disease: Heterozygous global GCK deletion produced mice with basal plasma glucose concentration increased by 60% at two days and 74% at six to ten weeks, decreased hepatic glycogen, mild hepatic steatosis, and impaired glucose tolerance and rate of hepatic glycogen synthesis, compared with wildtype controls.